pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Jul 22·1 min read
save

NIH joins Trump’s $5B AI Genesis Mission to boost biomedical research

Jul 22, 2026·read at Fierce Biotech ↗RegulatoryPositive

The U.S. Department of Health and Human Services announced that the National Institutes of Health will take part in the President’s Genesis Mission, a $5 billion AI-driven effort.

The initiative aims to accelerate biomedical discoveries, with emphasis on chronic disease, pediatric cancer, and faster drug development, using AI models and autonomous labs.

More than 15 federal agencies will contribute funding, data sets, and research facilities, expanding the whole-government collaboration that began under the Department of Energy.

The program follows a 2025 executive order and reflects the administration’s focus on applying advanced computing to uncover disease mechanisms and improve clinical translation.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “NIH joins Trump’s $5B AI mission with biomedical research push”

read at Fierce Biotech ↗
836 words · retrieved Jul 22
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health4Ultragenyx Pharmaceutical Inc.
topics
Oncology4Rare Disease

related stories

  • Aug 20Chutes & Ladders—Neumora shuffles leadership ahead of INDFierce Biotech
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jul 20How Kyverna rode CAR T’s autoimmune wave to the FDA’s doorBioSpace
  • May 16Opinion: Marty Makary misunderstood something fundamental about the FDASTAT
  • May 11STAT+: Five years after disaster, a rare disease community gets new chance at treatmentSTAT